TAVR (TAVI)

Video

Use of Transcatheter Heart Valve for Improving Outcomes in High-Risk Redo Cardiac Surgery

August 19, 2026 | Kamran Babazadeh

Valve-in-valve transcatheter aortic valve implantation (TAVI) is a valuable therapeutic option for managing degenerated bioprosthetic valves, particularly in elderly, high-risk patients. However, careful patient selection and thorough anatomical assessment are crucial to ensure the safety...

Podcast

The Beat With Joel Dunning Ep. 177: Expert Consensus Document on LVRS for Emphysema

October 15, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...

Video

The Value of the Heart Team: Perspectives From Vincent Gaudiani and Chad Rammohan

October 2, 2026 | Vincent GaudianiGold ContributorBronze Commentor

In this discussion, CTSNet Senior Editor—Education Vincent Gaudiani, a Clinical Associate Professor of Cardiothoracic Surgery at Stanford University in Stanford, California, USA, and Chad Rammohan, an interventional and structural cardiologist...

Video

ECS Club | Can the Endoscope “Challenge” the Catheter?

September 26, 2026 | Joseph Zacharias

This talk features Joseph Zacharias, a consultant cardiothoracic surgeon at the Lancashire Cardiac Center in Blackpool, England, delivering a presentation on “Can the Endoscope ‘Challenge’ the Catheter?” at the Endoscopic...

Video

The TAVR Heart Team in 2026: Navigating the CMS Decision | A CTSNet Webinar

September 18, 2026 | Tom C. NguyenSilver Contributor…

CTSNet hosted a webinar on September 15, 2026, titled “The TAVR Heart Team in 2026: Navigating the CMS Decision,” featuring leading surgeons Tom B. Nguyen, Michael Mack, and Tsuyoshi Kaneko,...

JANS Article

Reduced Leaflet Motion After Transcatheter Aortic Valve Replacement

November 22, 2019 | Aristotle ProtopapasGold ContributorGold Commentor

Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy : https://www.nejm.org/doi/full/10.1056/NEJMoa1911425?query=recirc_curatedRelated_article, And...

JANS Article

Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials

November 7, 2019 | Mark FergusonGold Contributor

Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were...

JANS Article

Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database

October 10, 2019 | Mark FergusonGold Contributor

Reporting of postmarket outcomes for the Sapien 3 and Mitraclip devices frequently misclassified patient deaths as device malfunction or other outcomes. Misclassification for Sapien 3 involved 17.5% of patient deaths,...

JANS Article

Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement

August 29, 2019 | Mark FergusonGold Contributor

Using an approach that minimizes valve depth relative to the membranous septum, the authors reduced the need for permanent pacemaker placement to a reliable and predictable 3% compared to the...

JANS Article

FDA Expands Indication for Several Transcatheter Heart Valves to Patients at Low Risk

August 16, 2019 | Mark FergusonGold Contributor

The FDA-approved use of TAVR has now expanded to low-risk patients with severe aortic stenosis. This includes both Edwards Lifesciences’ Sapien 3 and Sapien 3 Ultra as well as Medtronic’s...

Video

Early Migration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Causing Coronary Occlusion: A Practical Technique for Surgical Explantation

July 24, 2019 | Jordan Bloom…

Objectives Transcatheter aortic valve replacement (TAVR) has become the standard of care for high-risk patients and is growing in popularity for lower risk patients. The authors report a case of...

JANS Article

Transcatheter Valve-in-Valve Versus Surgical Replacement of Failing Stented Aortic Biological Valves

July 20, 2019 | Jessica LucSilver Contributor

This retrospective study by Sedeek et al aimed to compare the outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) valve-in-valve (n=90) versus surgical replacement (SAVR) (n=260) of failing stented...

JANS Article

In Global News: Long-Term Fontan Circulation, a Shock Team, and the TMVR Learning Curve

July 19, 2019 | Claire VernonGold Contributor

Patient Care and General Interest The American Heart Association published a statement advocating for a holistic care approach for patients with Fontan circulation, noting that these patients are living longer...

LOAD MORE
ADVERTISE ON CTSNET